Clostridium difficile infection and inflammatory bowel disease

References

• Bartlett JG, Moon N, Chang TW, Taylor N, Onderdonk AB. Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology 1978;75:778–82.
   PubMed Web of Science ®Google Scholar
• Larson HE, Parry JV, Price AB, Davies DR, Dolby J, Tyrrell DA. Un-described toxin in pseudomembranous colitis. Br Med J 1977;1:1246–8.
   PubMed Web of Science ®Google Scholar
• LaMont JT, Trnka YM. Therapeutic implications of Clostridium difficile toxin during relapse of chronic inflammatory bowel disease. Lancet 1980;1:381–3.
   PubMed Web of Science ®Google Scholar
• Bolton RP, Sherriff RJ, Read AE. Clostridium difficile associated diarrhoea: a role in inflammatory bowel disease? Lancet 1980;1:383–4.
   PubMed Web of Science ®Google Scholar
• Trnka YM, LaMont JT. Association of Clostridium difficile toxin with symptomatic relapse of chronic inflammatory bowel disease. Gastroenterology 1980;80:693–6.
   Google Scholar
• Keighley MR, Youngs D, Johnson M, Allan RN, Burdon DW. Clostridium difficile toxin in acute diarrhoea complicating inflammatory bowel disease. Gut 1982;23:410–14.
   PubMedGoogle Scholar
• Rolny P, Järnerot G, Möllby R. Occurrence of Clostridium difficile toxin in inflammatory bowel disease. Scand J Gastroenterol 1983;18:61–4.
   PubMed Web of Science ®Google Scholar
• Gurian L, Klein K, Ward TT. Role of Clostridium difficile and Campylobacter jejuni in relapses of inflammatory bowel disease. West J Med 1983;138:359–60.
   PubMedGoogle Scholar
• Burke DA, Axon AT. Clostridium difficile, sulphasalazine, and ulcerative colitis. Postgrad Med J 1987;63:955–7.
   PubMedGoogle Scholar
• Weber P, Koch M, Heizmann WR, Scheurlen M, Jenss H, Hartmann F. Microbic superinfection in relapse of inflammatory bowel disease. J Clin Gastroenterol 1992;14:302–8.
   PubMed Web of Science ®Google Scholar
• Mylonaki M, Langmead L, Pantes A, Johnson F, Rampton DS. Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool. Eur J Gastroenterol Hepatol 2004;16:775–8.
   PubMed Web of Science ®Google Scholar
• Meyer AM, Ramzan NN, Loftus EV, Heigh RI, Leighton JA. The diagnostic yield of stool pathogen studies during relapses of inflammatory bowel disease. J Clin Gastroenterol 2004;38:772–5.
   PubMed Web of Science ®Google Scholar
• Rodemann, JF, Dubberke ER, Reske KA, Seo da H, Stone CD. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol 2007;5:339–44.
   PubMed Web of Science ®Google Scholar
• Issa M, Vijayapal A, Graham MB, Beaulieu DB, Otterson MF, Lundeen S, Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol 2007;5:345–51.
   PubMed Web of Science ®Google Scholar
• Nguyen GC, Kaplan GG, Harris ML, Brant SR. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol 2008;103:1443–50.
   PubMed Web of Science ®Google Scholar
• Greenstein AJ, Byrn JC, Zhang LP, Swedish KA, Jahn AE, Divino CM. Risk factors for the development of fulminant Clostridium difficile colitis. Surgery 2008;143:623–9.
   PubMedGoogle Scholar
• Ricciardi R, Ogilvie JW Jr, Roberts PL, Marcello PW, Concannon TW, Baxter NN. Epidemiology of Clostridium difficile colitis in hospitalized patients with inflammatory bowel diseases. Dis Colon Rectum 2009;52:40–5.
   PubMed Web of Science ®Google Scholar
• Ananthakrishnan AN, McGinley EL, Binion DG. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut 2008;57:205–10.
   PubMed Web of Science ®Google Scholar
• Jodorkovsky D, Young Y, Abreu MT. Clinical outcomes of patients with ulcerative colitis and co-existing Clostridium difficile Infection. Dig Dis Sci 2009;Mar 3 [Epub ahead of print].
   PubMedGoogle Scholar
• UK IBD Audit: Second round: full national report and appendices, 2009. Available from: http://www.rcplondon.ac.uk/clinical-standards/ceeu/Current-work/Pages/UK-IBD-Audit.aspx#background.
   Google Scholar
• Caprilli R, Gassull MA, Escher JC, Moser G, Munkholm P, Forbes A, European Crohn's and Colitis Organisation. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut 2006;55 Suppl 1:36–58.
   PubMedGoogle Scholar
• Travis SPL, Stange EF, Lémann M, Øresland T, Bemelman WA, Chowers Y, European Crohn's and Colitis Organisation. European evidence-based Consensus on the management of ulcerative colitis: Current management. J Crohn's Colitis 2008;2:24–62.
   Google Scholar
• McLaren L, Bartlett J, Gitnick G, and the IBD Research Group. Infectious agents in inflammatory bowel disease (IBD): collaborative studies. Gastroenterology 1981;80:1228.
   Google Scholar
• Meyers S, Mayer L, Bottone E, Desmond E, Janowitz HD. Occurrence of Clostridium difficile toxin during the course of inflammatory bowel disease. Gastroenterology 1981;80:697–700.
   PubMed Web of Science ®Google Scholar
• Dorman SA, Liggoria E, Winn WC, Beeken WL. Isolation of Clostridium difficile from patients with inactive Crohn's disease. Gastroenterology 1982;82:1348–51.
   PubMedGoogle Scholar
• Tvede M, Willumsen, L. Clostridium difficile in patients with irritable bowel syndrome and ulcerative colitis. Lancet 1982;1:1124.
   PubMedGoogle Scholar
• Tremaine WJ, Billie J, Huizenga KA, Washington JA, Ilstrup DM. Factors which influence the occurrence of Clostridium dfficile infections in inflammatory bowel disease. Gastroenterology 1983;84:1337.
   Google Scholar
• Kochhar R, Ayyagari A, Goenka MK, Dhali GK, Aggarwal R, Mehta SK. Role of infectious agents in exacerbations of ulcerative colitis in India. A study of Clostridium difficile. J Clin Gastroenterol 1993;16:26–30.
   PubMed Web of Science ®Google Scholar
• Clayton EM, Rea MC, Shanahan F, Quigley EM, Kiely B, Hill C, The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission. Am J Gastroenterol 2009;104:1162–9.
   PubMed Web of Science ®Google Scholar
• Wang Y, Shen B. Clostridium difficile-associated diarrhea in Crohn's disease patients with Ostomy. Inflamm Bowel Dis 2009;Apr 30 [Epub ahead of print].
   PubMedGoogle Scholar
• Shen BO, Jiang ZD, Fazio VW, Remzi FH, Rodriguez L, Bennett AE, Clostridium difficile infection in patients with ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol 2008;6:782–8.
   PubMed Web of Science ®Google Scholar
• Health Protection Agency. Clostridium difficile infection: How to deal with the problem, 2009. Availablefrom: http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1232006607827.
   Google Scholar
• Kuijper EJ, Coignard B, Tüll P. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 2006;12(Suppl 6):2–18.
   PubMed Web of Science ®Google Scholar
• McDonald LV, Coignard B, Dubberbeke E, Song X, Horan T, Kutty PK. The Centre for Disease Control and Prevention. Surveillance definitions for Clostridium difficile-associated disease, 2007. Available from: http://www.cdc.gov/ncidod/dhqp/pdf/surveillance/Surveillance_c_diff.pdf.
   Google Scholar
• Stange EF, Travis SP, Vermeire S, Beglinger C, Kupcinkas L, Geboes K, European Crohn's and Colitis Organisation (ECCO). European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut 2006;55(Suppl 1):1–15.
   Google Scholar
• D'Haens G, Sandborn WJ, Feagan BG, Geboes K, Hanauer SB, Irvine EJ, A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 2007;132:763–86.
   PubMed Web of Science ®Google Scholar
• Stange EF, Travis SP, Vermeire S, Beglinger C, Kupcinkas L, Geboes K, , for the European Crohn's and Colitis Organisation (ECCO). European evidence-based consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis, 2007. Available from: http://www.ecco-ibd.eu/publications/guidelines.php?navId=30.
   Google Scholar
• McFarland LV. Update on the changing epidemiology of Clostridium difficile-associated disease. Nat Clin Pract Gastroenterol Hepatol 2008;5:40–8.
   PubMedGoogle Scholar
• Powell N, Jung SE, Krishnan B. Clostridium difficile infection and inflammatory bowel disease: a marker for disease extent? Gut 2008;57:1183–4.
   PubMed Web of Science ®Google Scholar
• Ben-Horin S, Margalit M, Bossuyt P, Maul J, Shapira Y, Bojic D, European Crohn's and Colitis Organization (ECCO). Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and clostridium difficile infection. Clin Gastroenterol Hepatol 2009;7:981–7.
   PubMed Web of Science ®Google Scholar
• Schneeweiss S, Korzenik J, Solomon DH, Canning C, Lee J, Bressler B. Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections. Aliment Pharmacol Ther 2009;30:253–64.
   PubMed Web of Science ®Google Scholar
• Greenfield C, Aguilar Ramirez JR, Pounder RE, Williams T, Danvers M, Marper SR, Clostridium difficile and inflammatory bowel disease. Gut 1983;24:713–7.
   PubMed Web of Science ®Google Scholar
• Toruner M, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Orenstein R, Sandborn WJ, Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology 2008;134:929–36.
   PubMed Web of Science ®Google Scholar
• Tremaine WJ. Inflammatory bowel disease and Clostridium difficile-associated diarrhea: a growing problem. Clin Gastroenterol Hepatol 2007;5:310–11.
   PubMedGoogle Scholar
• Sunenshine RH, McDonald LC, for the Centre for Disease Control and Prevention Surveillance Clostridium difficile-associated disease: New challenges from an established pathogen, 2006. Available from: http://www.cdc.gov/ncidod/dhqp/id_Cdiff.html.
   Google Scholar
• Issa M, Ananthakrishnan AN, Binion DG. Clostridium difficile and inflammatory bowel disease. Inflamm Bowel Dis 2008;14:1432–42.
   PubMed Web of Science ®Google Scholar
• Navaneethan U, Giannella RA. Thinking beyond the colon–small bowel involvement in Clostridium difficile infection. Gut Pathog 2009;1:7.
   PubMedGoogle Scholar
• Poutanen SM, Simor AE. Clostridium difficile-associated diarrhea in adults. CMAJ 2004;171:51–8.
   PubMed Web of Science ®Google Scholar
• Bartlett JG. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 2002;346:334–9.
   PubMed Web of Science ®Google Scholar
• Owens RC, Donskey CJ, Gaynes RP, Loo VG, Muto CA. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis 2008;46(Suppl 1):19–31.
   PubMed Web of Science ®Google Scholar
• Warny M, Vaerman JP, Avesani V, Delmée M. Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection. Infect Immun 1994;62:384–9.
   PubMed Web of Science ®Google Scholar
• Kelly CP, Pothoulakis C, LaMont, JT. Clostridium difficile colitis. N Engl J Med 1994;330:257–62.
   PubMed Web of Science ®Google Scholar
• Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007;448:427–34.
   PubMed Web of Science ®Google Scholar
• Sonnenberg A. Similar geographic variations of mortality and hospitalization associated with IBD and Clostridium difficile colitis. Inflamm Bowel Dis 2009; Jul 27 [Epub ahead of print].
   Google Scholar
• Nomura K, Fujimoto Y, Yamashita M, Morimoto Y, Ohshiro M, Sato K, Absence of pseudomembranes in Clostridium difficile-associated diarrhea in patients using immunosuppression agents. Scand J Gastroenterol 2009;44:74–8.
   PubMed Web of Science ®Google Scholar
• Wang A, Takeshima F, Ikeda M, Ohnita K, Furusu H, Isomoto H, Ulcerative colitis complicating pseudomembranous colitis of the right colon. J Gastroenterol 2002;37:309–12.
   PubMedGoogle Scholar
• García-Osogobio S, Takahashi T, Gamboa-Domínguez A, Medina H, Arch J, Mass W, Toxic pseudomembranous colitis in a patient with ulcerative colitis. Inflamm Bowel Dis 2000;6:188–90.
   PubMedGoogle Scholar
• Chen FC, Woods R. Pseudomembranous panenteritis and septicaemia in a patient with ulcerative colitis. Aust N Z J Surg 1996;66:565–7.
   PubMedGoogle Scholar
• Giesemann T, Guttenberg G, Aktories K. Human alpha-defensins inhibit Clostridium difficile toxin B. Gastroenterology 2008;134:2049–58.
   PubMed Web of Science ®Google Scholar
• Salzman NH. Defensins versus bacteria: not just antibiotics anymore. Gastroenterology 2008;134:2174–7.
   PubMedGoogle Scholar
• Ramasundara M, Leach ST, Lemberg DA, Day AS. Defensins and inflammation: the role of defensins in inflammatory bowel disease. J Gastroenterol Hepatol 2009;24:202–8.
   PubMed Web of Science ®Google Scholar
• Savoye G. Alpha-defensins and Clostridium difficile recent growing concerns in inflammatory bowel disease. Am J Gastroenterol 2008;103:3215.
   PubMedGoogle Scholar
• Testore GP, Nardi F, Babudieri S, Giuliano M, Di Rosa R, Panichi G. Isolation of Clostridium difficile from human jejunum: identification of a reservoir for disease? J Clin Pathol 1986;39:861–2.
   PubMedGoogle Scholar
• Linskens RK, Huijsdens XW, Savelkoul PH, Vandenbroucke-Grauls CM, Meuwissen SG. The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics. Scand J Gastroenterol 2001;234:29–40.
   Google Scholar
• Ott SJ, Musfeldt M, Wenderoth DF, Hampe J, Brant O, Fölsch UR, Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 2004;53:685–93.
   PubMed Web of Science ®Google Scholar
• Sorg JA, Sonenshein AL. Bile salts and glycine as cogerminants for Clostridium difficile spores. J Bacteriol 2008;190:2505–12.
   PubMed Web of Science ®Google Scholar
• Williams RN, Hemingway D, Miller AS. Enteral Clostridium difficile, an emerging cause for high-output ileostomy. J Clin Pathol 2009;62:951–3.
   PubMed Web of Science ®Google Scholar
• Mann SD, Pitt J, Springall RG, Thillainayagam AV. Clostridium difficile infection–-an unusual cause of refractory pouchitis: report of a case. Dis Colon Rectum 2003;46:267–70.
   PubMed Web of Science ®Google Scholar
• Shen B, Goldblum JR, Hull TL, Remzi FH, Bennett AE, Fazio VW. Clostridium difficile-associated pouchitis. Dig Dis Sci 2006;51:2361–4.
   PubMed Web of Science ®Google Scholar
• Boland E, Thompson JS. Fulminant Clostridium difficile enteritis after proctocolectomy and ileal pouch-anal anastamosis. Gastroenterol Res Pract 2008;2008:985658.
   Google Scholar
• Gerding DN, Muto CA, Owens RC Jr. Treatment of Clostridium difficile infection. Clin Infect Dis 2008;46(Suppl 1):S32–42.
   PubMed Web of Science ®Google Scholar
• Kuntz DP, Shortsleeve MJ, Kantrowitz PA, Gauvin GP. Clostridium difficile enteritis. A cause of intramural gas. Dig Dis Sci 1993;38:1942–4.
   PubMed Web of Science ®Google Scholar
• Vesoulis Z, Williams G, Matthews B. Pseudomembranous enteritis after proctocolectomy: report of a case. Dis Colon Rectum 2000;43:551–4.
   PubMed Web of Science ®Google Scholar
• Freiler JF, Durning SJ, Ender PT. Clostridium difficile small bowel enteritis occurring after total colectomy. Clin Infect Dis 2001;33:1429–31.
   PubMed Web of Science ®Google Scholar
• Kim KA, Wry P, Hughes E Jr, Butcher J, Barbot D. Clostridium difficile small-bowel enteritis after total proctocolectomy: a rare but fatal, easily missed diagnosis. Report of a case. Dis Colon Rectum 2007;50:920–3.
   PubMedGoogle Scholar
• Lundeen SJ, Otterson MF, Binion DG, Carman ET, Peppard WJ. Clostridium difficile enteritis: an early postoperative complication in inflammatory bowel disease patients after colectomy. J Gastrointest Surg 2007;11:138–42.
   PubMed Web of Science ®Google Scholar
• Wood MJ, Hyman N, Hebert JC, Blaszyk H. Catastrophic Clostridium difficile enteritis in a pelvic pouch patient: report of a case. J Gastrointest Surg 2008;12:350–2.
   PubMedGoogle Scholar
• Follmar KE, Condron SA, Turner II, Nathan JD, Ludwig KA. Treatment of metronidazole-refractory Clostridium difficile enteritis with vancomycin. Surg Infect (Larchmt) 2008;9:195–200.
   PubMedGoogle Scholar
• Yafi FA, Selvasekar CR, Cima RR. Clostridium difficile enteritis following total colectomy. Tech Coloproctol 2008;12:73–4.
   PubMedGoogle Scholar
• Fleming F, Khursigara N, O'Connell N, Darby S, Waldron D. Fulminant small bowel enteritis: a rare complication of Clostridium difficile-associated disease. Inflamm Bowel Dis 2009;15:801–2.
   PubMedGoogle Scholar
• Croagh DG, Bach SP, Keck J. A rare cause of acute abdomen after proctocolectomy. Am J Surg 2009;197:41–2.
   Google Scholar
• Shen B, Remzi FH, Fazio VW. Fulminant Clostridium difficile-associated pouchitis with a fatal outcome. Nat Rev Gastroenterol Hepatol 2009;6:492–5.
   PubMedGoogle Scholar
• Planche T, Aghaizu A, Holliman R, Riley P, Poloniecki J, Breathnach A, Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review. Lancet Infect Dis 2008;8:777–84.
   PubMed Web of Science ®Google Scholar
• Johnson S, Homann SR, Bettin KM, Quick JN, Clabots CR, Peterson CL, Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial. Ann Intern Med 1992;117:297–302.
   PubMed Web of Science ®Google Scholar
• Vonberg RP, Kuijper EJ, Wilcox MH, Barbut F, Tüll P, Gastmeier P, Infection control measures to limit the spread of Clostridium difficile. Clin Microbiol Infect 2008;14(Suppl 5):2–20.
   PubMedGoogle Scholar
• Teasley DG, Gerding DN, Olson MM, Peterson LR, Gebhard RL, Schwartz MJ, Prospective randomised trial of metronidazole versus vancomycin for Clostridium difficile-associated diarrhoea and colitis. Lancet 1983;2:1043–6.
   PubMed Web of Science ®Google Scholar
• Wenisch C, Parschalk B, Hasenhundl M, Hirschl AM, Graninger W. Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. Clin Infect Dis 1996;22:813–8.
   PubMed Web of Science ®Google Scholar
• Chang TW, Gorbach SL, Bartlett, JG. Inhibition of binding of Clostridium difficile toxin by steroids. J Infect Dis 2008;142:113.
   Google Scholar
• Castagliuolo I, Karalis K, Valenick L, Pasha A, Nikulasson S, Wlk M, Endogenous corticosteroids modulate Clostridium difficile toxin A-induced enteritis in rats. Am J Physiol Gastrointest Liver Physiol 2001;280:G539–45.
   PubMedGoogle Scholar
• Binion DG. Management of Clostridium difficile infection in inflammatory bowel disease. Gastroenterol Hepatol 2009;5:253–6.
   Google Scholar
• Musher DM, Aslam S, Logan N, Nallacheru S, Bhaila I, Borchert F, Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis 2006;40:1586–90.
   Google Scholar
• Nair S, Yadav D, Corpuz M, Pitchumoni CS. Clostridium difficile colitis: factors influencing treatment failure and relapse–a prospective evaluation. Am J Gastroenterol 1998;93:1873–6.
   PubMed Web of Science ®Google Scholar
• Pepin J, Alary ME, Valiquette L, Raiche E, Ruel J, Fulop K, Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis 2005;40:1591–7.
   PubMed Web of Science ®Google Scholar
• Hermsen JL, Dobrescu C, Kudsk KA. Clostridium difficile infection: a surgical disease in evolution. J Gastrointest Surg 2008;12:1512–17.
   PubMedGoogle Scholar
• Synnott K, Mealy K, Merry C, Kyne L, Keane C, Quill R. Timing of surgery for fulminating pseudomembranous colitis. Br J Surg 1998;85:229–31.
   PubMedGoogle Scholar
• Chan S, Kelly M, Helme S, Gossage J, Modarai B, Forshaw M. Outcomes following colectomy for Clostridium difficile colitis. Int J Surg 2009;7:78–81.
   PubMed Web of Science ®Google Scholar
• Koss K, Clark MA, Sanders DS, Morton D, Keighley MR, Goh J. The outcome of surgery in fulminant Clostridium difficile colitis. Colorectal Dis 2006;8:149–54.
   PubMed Web of Science ®Google Scholar
• Berman L, Carling T, Fitzgerald TN, Bell RL, Duffy AJ, Longo WE, Defining surgical therapy for pseudomembranous colitis with toxic megacolon. J Clin Gastroenterol 2008;42:476–80.
   PubMedGoogle Scholar
• Jaber MR, Olafsson S, Fung WL, Reeves ME. Clinical review of the management of fulminant Clostridium difficile infection. Am J Gastroenterol 2008;103:3195–203.
   PubMed Web of Science ®Google Scholar
• Pepin J, Vo TT, Boutros M, Marcotte E, Dial S, Dubé S, Risk factors for mortality following emergency colectomy for fulminant Clostridium difficile infection. Dis Colon Rectum 2009;52:400–5.
   PubMed Web of Science ®Google Scholar
• Issa M, Weber LR, Skaros S, Dawn M, Borromeo B, Emmons J, Decreasing rates of colectomy despite high rates of hospitalization in Clostridium difficile infected IBD patients: a tertiary referral center experience. Gastroenterology 2007;132:A663.
   Google Scholar
• Johnson S. Recurrent Clostridium difficile infection: causality and therapeutic approaches. Int J Antimicrob Agents 2009;33(Suppl 1):S33–6.
   PubMedGoogle Scholar
• Bauer MP, van Dissel JT, Kuijper EJ. Clostridium difficile: controversies and approaches to management. Curr Opin Infect Dis 2009;22:517–24.
   PubMed Web of Science ®Google Scholar